Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Danzl, K; Messner, B; Doppler, C; Nebert, C; Abfalterer, A; Sakic, A; Temml, V; Heinz, K; Streitwieser, R; Edelmann, T; Mairhofer, M; Grimm, M; Laufer, G; Zierer, A; Stuppner, H; Schuster, D; Ploner, C; Müller, T; Bernhard, D.
Early inhibition of endothelial retinoid uptake upon myocardial infarction restores cardiac function and prevents cell, tissue, and animal death.
J Mol Cell Cardiol. 2019; 126: 105-117. Doi: 10.1016/j.yjmcc.2018.11.012
Web of Science PubMed FullText FullText_MUG

 

Co-Autor*innen der Med Uni Graz
Nebert Clemens
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Physiologically, following myocardial infarction (MI), retinoid levels elevate locally in the infarcted area. Whereas therapeutic systemic application of retinoids was shown to reduce the progression of ventricular dilatation and the onset of heart failure, the role of acute physiologically increased retinoids in the infarction zone is unknown to date. To reveal the role of local retinoids in the MI zone is the central aim of this study. Using human cell culture and co-culture models for hypoxia as well as various assays systems, lentivirus-based transgene expression, in silico molecular docking studies, and an MI model in rats, we analysed the impact of the retinoid all-trans retinoic acid (ATRA) on cell signalling, cell viability, tissue survival, heart function, and MI-induced death in rats. Based on our results, ATRA-mediated signalling does aggravate the MI phenotype (e.g. 2.5-fold increased mortality compared to control), whereas 5'-methoxyleoligin (5ML), a new agent which interferes with ATRA-signalling rescues the ATRA-dependent phenotype. On the molecular level, ATRA signalling causes induction of TXNIP, a potent inhibitor of the physiological antioxidant thioredoxin (TRX1) and sensitizes cells to necrotic cell death upon hypoxia. 5ML-mediated prevention of ATRA effects were shown to be based on the inhibition of cellular ATRA uptake by interference with the cholesterol (and retinol) binding motif of the transmembrane protein STRA6. 5ML-mediated inhibition of ATRA uptake led to a strong reduction of ATRA-dependent gene expression, reduced ROS formation, and protection from necrotic cell death. As 5ML exerted a cardioprotective effect, also independent of its inhibition of cellular ATRA uptake, the agent likely has another cardioprotective property, which may rely on the induction of TRX1 activity. In summary, this is the first study to show i) that local retinoids in the early MI zone may worsen disease outcome, ii) that inhibition of endothelial retinoid uptake using 5ML may constitute a novel treatment strategy, and iii) that targeting endothelial and myocardial retinoid uptake (e.g. via STRA6 inhibition) may constitute a novel treatment target in acute MI.
Find related publications in this database (using NLM MeSH Indexing)
Animals - administration & dosage
Cell Cycle Proteins - metabolism
Cell Death - drug effects
Cell Hypoxia - drug effects
Human Umbilical Vein Endothelial Cells - metabolism, pathology
Humans - administration & dosage
Lignans - pharmacology
Male - administration & dosage
Myocardial Infarction - metabolism, physiopathology
Myocardium - metabolism, pathology
Oxidative Stress - drug effects
Rats - administration & dosage
Retinoids - metabolism
Signal Transduction - drug effects

Find related publications in this database (Keywords)
Retinoids
Retinol
ATRA
CYP26B1
STRA6
Cardioprotection
Leoligin
5 '-methoxyleoligin
© Med Uni Graz Impressum